These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 10088075)

  • 1. [The treatment of familial hypercholesterolemia and of the dyslipidemias responsible for cardiovascular disease].
    Sampietro T; Licitra R
    G Ital Cardiol; 1999 Feb; 29(2):171-3. PubMed ID: 10088075
    [No Abstract]   [Full Text] [Related]  

  • 2. Premature cardiovascular disease in young women with heterozygous familial hypercholesterolemia.
    van der Graaf A; Hutten BA; Kastelein JJ; Vissers MN
    Expert Rev Cardiovasc Ther; 2006 May; 4(3):345-51. PubMed ID: 16716095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recommendations for the management of dyslipidemia and the prevention of cardiovascular disease: summary of the 2003 update.
    Genest J; Frohlich J; Fodor G; McPherson R;
    CMAJ; 2003 Oct; 169(9):921-4. PubMed ID: 14581310
    [No Abstract]   [Full Text] [Related]  

  • 4. Familial hypercholesterolemia: current treatment and advances in management.
    Huijgen R; Vissers MN; Defesche JC; Lansberg PJ; Kastelein JJ; Hutten BA
    Expert Rev Cardiovasc Ther; 2008 Apr; 6(4):567-81. PubMed ID: 18402545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low adherence of General Practitioners to National Cholesterol Education Program guidelines for the management of hyperlipidaemia.
    Fornengo P; Bruno G; De Salvia A; Arcari R; Pisu E; Pagano G
    Diabetes Nutr Metab; 2000 Oct; 13(5):263-8. PubMed ID: 11105968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperlipidemia and cardiovascular disease with focus on familial hypercholesterolemia.
    Holven KB; Ulven SM; Bogsrud MP
    Curr Opin Lipidol; 2017 Oct; 28(5):445-447. PubMed ID: 28857860
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hyperlipidemia: therapeutic principles in clinical practice].
    Müller-Wieland D; Krone W
    Med Klin (Munich); 2003 Dec; 98(12):739-43. PubMed ID: 14685674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic determinants of cardiovascular disease risk in familial hypercholesterolemia.
    Jansen AC; van Aalst-Cohen ES; Tanck MW; Cheng S; Fontecha MR; Li J; Defesche JC; Kastelein JJ
    Arterioscler Thromb Vasc Biol; 2005 Jul; 25(7):1475-81. PubMed ID: 15879303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Familial hypercholesterolemia and cardiovascular disease a top concern for women.
    Gish BA
    Nurs Womens Health; 2009 Feb; 13(1):30-7. PubMed ID: 19207502
    [No Abstract]   [Full Text] [Related]  

  • 10. Distribution of risk factors, plasma lipids, lipoproteins and dyslipidemias in a small Mediterranean island: the Ustica Project.
    Barbagallo CM; Polizzi F; Severino M; Onorato F; Noto D; Cefalù AB; Rizzo M; Notarbartolo A; Averna MR
    Nutr Metab Cardiovasc Dis; 2002 Oct; 12(5):267-74. PubMed ID: 12616806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical applications of long-term LDL-apheresis on and beyond refractory hypercholesterolemia.
    Mabuchi H; Higashikata T; Kawashiri MA
    Transfus Apher Sci; 2004 Jun; 30(3):233-43. PubMed ID: 15172629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Grand rounds from Rutgers Medical School. Familial hypercholesterolemia.
    Conn HL; Kuo PT; Khachadurian AK; Kostis JB
    Med Times; 1980 Apr; 108(4):112-6, 123-9. PubMed ID: 7360031
    [No Abstract]   [Full Text] [Related]  

  • 13. K/DOQI clinical practice guidelines for management of dyslipidemias in patients with kidney disease.
    Kidney Disease Outcomes Quality Initiative (K/DOQI) Group
    Am J Kidney Dis; 2003 Apr; 41(4 Suppl 3):I-IV, S1-91. PubMed ID: 12671933
    [No Abstract]   [Full Text] [Related]  

  • 14. [Is statin treatment for children safe and effective?].
    Marchetti F; Cannioto Z
    Recenti Prog Med; 2008 Dec; 99(12):599-601. PubMed ID: 19388217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recommendations for the management and treatment of dyslipidemia. Report of the Working Group on Hypercholesterolemia and Other Dyslipidemias.
    Fodor JG; Frohlich JJ; Genest JJ; McPherson PR
    CMAJ; 2000 May; 162(10):1441-7. PubMed ID: 10834048
    [No Abstract]   [Full Text] [Related]  

  • 16. [The diagnosis and treatment of hypercholesterolemia and other hyperlipidemias in children--recommendations of the Finnish Pediatricians' Association].
    Salo MK; Viikari J; Nuutinen M; Kaitila I; Sipilä I; Akerblom H; Komulainen J; Siimes M; Simell O
    Duodecim; 1994; 110(18):1719-23. PubMed ID: 7555763
    [No Abstract]   [Full Text] [Related]  

  • 17. [Primary prevention of cardiovascular disease].
    Gohlke H
    Dtsch Med Wochenschr; 2005 Jan; 130(1-2):38-43. PubMed ID: 15619173
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of patients with high cardiovascular risk in general practice].
    Ilyés I; Erdei I; Jancsó Z
    Orv Hetil; 2004 Aug; 145(33):1723-6. PubMed ID: 15462478
    [No Abstract]   [Full Text] [Related]  

  • 19. The application of molecular biology techniques to the diagnosis of hyperlipidaemia and other risk factors for cardio-vascular disease.
    Humphries SE
    Ann Biol Clin (Paris); 1994; 52(1):67-75. PubMed ID: 8210077
    [No Abstract]   [Full Text] [Related]  

  • 20. [Familial hypercholesterolemia].
    Widhalm K
    Dtsch Med Wochenschr; 2000 Jan; 125(4):99. PubMed ID: 10733301
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.